RxDoctor Payments DataLook up a doctor →

Angel Rico, MD

General Practice · Miami Lakes, FLNPI 1417166091

Payments from drug & device makers

$2,897,109in general payments, 2019–2025

Across 1,108 payments — averaging $2614.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2.2M
  • Pfizer$371K
  • Sanofi Pasteur Inc.$210K
  • Avanir Pharmaceuticals, Inc.$81K
  • Takeda Pharmaceuticals U.S.A., Inc.$26K
  • Shire North American Group Inc$14K
  • plus $11K from 10 others

What the payments were for

  • Food & beverage$148100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,897,109 in reported general payments places this provider in the 95th percentile of 6,901 general practice providers in Florida.

See all general practice providers in Florida

Medicare billing

Part B allowed, 2024
$7,485
Medicare patients
23
Services billed
81

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban16$10,692
JardianceEmpagliflozin11$7,927
BrilintaTicagrelor12$7,835
Glipizide38$654
Bupropion XlBupropion Hcl14$647
Wixela InhubFluticasone Propion/Salmeterol16$486
Atorvastatin Calcium51$473
Losartan Potassium78$437
Oxybutynin Chloride ErOxybutynin Chloride13$414
Pantoprazole Sodium31$384
Nifedipine ErNifedipine20$379
ClopidogrelClopidogrel Bisulfate14$305
Montelukast Sodium35$249
Lisinopril64$248
Amlodipine Besylate41$243

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$370,869$10,69216 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,901 general practice providers in Florida.

Other general practice in Miami Lakes

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →